Expressing support for the designation of February 29, 2024, as "Rare Disease Day".
Impact
If adopted, HR1036 serves to enhance public knowledge about rare diseases and the challenges faced by those living with such conditions. By recognizing Rare Disease Day, the bill aims to rally support for ongoing and future initiatives geared towards finding cures and improving medical care and diagnostics for rare diseases. The resolution aligns with recent legislative efforts and programs established by the FDA and other institutions aimed at facilitating drug development for rare diseases.
Summary
House Resolution 1036 expresses support for the designation of February 29, 2024, as 'Rare Disease Day.' This bill underscores the importance of raising awareness about rare diseases, of which more than 7,000 are recognized, affecting approximately 25 million individuals in the U.S. alone. The resolution emphasizes the need for better diagnostic capabilities and the importance of supporting both national and global efforts in the research for effective treatments and cures for patients dealing with these conditions.
Contention
While HR1036 is primarily supportive, it does highlight ongoing areas of contention within healthcare regarding accessibility to treatments and the challenges that continue to face individuals with rare diseases, especially concerning health insurance coverage and availability of specialized medical professionals. Notably, this resolution is part of a broader context where over 90% of rare diseases currently lack FDA-approved treatments, which raises concerns about healthcare equity and the urgency for innovation in medical research.